Belkaid Y - Search Results

1

Wohlfert E, Belkaid Y. Wohlfert E, et al. Among authors: belkaid y. Mucosal Immunol. 2010 May;3(3):213-5. doi: 10.1038/mi.2010.11. Epub 2010 Mar 17. Mucosal Immunol. 2010. PMID: 20237465 Free PMC article. Review.

2

Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly?

Belkaid Y, Valenzuela JG, Kamhawi S, Rowton E, Sacks DL, Ribeiro JM. Belkaid Y, et al. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6704-9. doi: 10.1073/pnas.97.12.6704. Proc Natl Acad Sci U S A. 2000. PMID: 10841567 Free PMC article.

3

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. Belkaid Y, et al. J Immunol. 2000 Jul 15;165(2):969-77. doi: 10.4049/jimmunol.165.2.969. J Immunol. 2000. PMID: 10878373 Free article.

4

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

Méndez S, Gurunathan S, Kamhawi S, Belkaid Y, Moga MA, Skeiky YA, Campos-Neto A, Reed S, Seder RA, Sacks D. Méndez S, et al. Among authors: belkaid y. J Immunol. 2001 Apr 15;166(8):5122-8. doi: 10.4049/jimmunol.166.8.5122. J Immunol. 2001. PMID: 11290794 Free article.

5

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL. Belkaid Y, et al. J Exp Med. 2001 Nov 19;194(10):1497-506. doi: 10.1084/jem.194.10.1497. J Exp Med. 2001. PMID: 11714756 Free PMC article.

6

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D. Belkaid Y, et al. J Immunol. 2002 Apr 15;168(8):3992-4000. doi: 10.4049/jimmunol.168.8.3992. J Immunol. 2002. PMID: 11937556 Free article.

7

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. Belkaid Y, et al. Nature. 2002 Dec 5;420(6915):502-7. doi: 10.1038/nature01152. Nature. 2002. PMID: 12466842

8

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Mendez S, Tabbara K, Belkaid Y, Bertholet S, Verthelyi D, Klinman D, Seder RA, Sacks DL. Mendez S, et al. Among authors: belkaid y. Infect Immun. 2003 Sep;71(9):5121-9. doi: 10.1128/IAI.71.9.5121-5129.2003. Infect Immun. 2003. PMID: 12933855 Free PMC article.

9

Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia.

Feng CG, Collazo-Custodio CM, Eckhaus M, Hieny S, Belkaid Y, Elkins K, Jankovic D, Taylor GA, Sher A. Feng CG, et al. Among authors: belkaid y. J Immunol. 2004 Jan 15;172(2):1163-8. doi: 10.4049/jimmunol.172.2.1163. J Immunol. 2004. PMID: 14707092 Free article.

10

The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.

Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. Hesse M, et al. Among authors: belkaid y. J Immunol. 2004 Mar 1;172(5):3157-66. doi: 10.4049/jimmunol.172.5.3157. J Immunol. 2004. PMID: 14978122 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results